Who Paid My Doc
Barhemsys
Drug Post Operative Nausea and Vomiting
NDC 71390-125-20
General payments
$474,122
Research payments
$0
Through program year 2024, $474,122 in general payments and $0 in research payments were reported against Barhemsys (Post Operative Nausea and Vomiting).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $52,501 | 767 |
| 2023 | General | $208,384 | 2,310 |
| 2022 | General | $213,238 | 795 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
3,872 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.